Machine Learning Based Drug Repurposing Strategies for Predicting Drug-Target Interactions

References

[1] X. Chen, C. C. Yan, X. Zhang, X. Zhang, F. Dai, J. Yin, and Y. Zhang, “Drug–target interaction prediction: databases, web servers and computational models,” Briefings in Bioinformatics, vol. 17, no. 4, pp. 696–712, Aug. 2015.

[2] R. Gupta, D. Srivastava, M. Sahu, S. Tiwari, R. K. Ambasta, and P. Kumar, “Artificial intelligence to deep learning: machine intelligence approach for drug discovery,” Molecular Diversity, vol. 25, no. 3, pp. 1315–1360, Apr. 2021.

[3] S.-S. Ou-Yang, J.-Y. Lu, X.-Q. Kong, Z.-J. Liang, C. Luo, and H. Jiang, “Computational drug discovery,” Acta Pharmacologica Sinica, vol. 33, no. 9, pp. 1131–1140, Aug. 2012.

[4] J. Vamathevan, D. Clark, P. Czodrowski, I. Dunham, E. Ferran, G. Lee, B. Li, A. Madabhushi, P. Shah, M. Spitzer, and S. Zhao, “Applications of machine learning in drug discovery and development, Nature Reviews Drug Discovery, vol. 18, no. 6, pp. 463 477, Apr. 2019.

[5] F. Cheng, I. A. KovaCs, and A.-L. BarabaSi, Network-based prediction of drug combinations, Nature Communications, vol. 10, no. 1, Mar. 2019.

[6] R. Chen, X. Liu, S. Jin, J. Lin, and J. Liu, Machine Learning for Drug-Target Interaction Prediction, Molecules, vol. 23, no. 9, p. 2208, Aug. 2018.

[7] F. Cheng, C. Liu, J. Jiang, W. Lu, W. Li, G. Liu, W. Zhou, J. Huang, and Y. Tang, “Prediction of Drug-Target Interactions and drug repositioning via Network-Based inference,” PLoS Computational Biology, vol. 8, no. 5, p. e1002503, May 2012.

[8] N. T. Issa, V. Stathias, S. Schürer, and S. Dakshanamurthy, “Machine and deep learning approaches for cancer drug repurposing,” Seminars in Cancer Biology, vol. 68, pp. 132–142, Jan. 2020.

[9] J. You, R. D. McLeod, and P. Hu, “Predicting drug-target interaction network using deep learning model,” Computational Biology and Chemistry, vol. 80, pp. 90–101, Mar. 2019.

[10] S. Dara, S. Dhamercherla, S. S. Jadav, C. M. Babu, and M. J. Ahsan, “Machine Learning in Drug Discovery: A review,” Artificial Intelligence Review, vol. 55, no. 3, pp. 1947–1999, Aug. 2021.

[11] A. S. Rifaioglu, H. Atas, M. J. Martin, R. Cetin-Atalay, V. Atalay, and T. Doan, Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases, Briefings in Bioinformatics, vol. 20, no. 5, pp. 1878 1912, Jun. 2018.

[12] H. Shi, S. Liu, J. Chen, X[\ijor|}~+ , 5 < = > { | À Å Æ Ç È ÈÈ [Some characters in this reference could not be displayed correctly — please refer to the published PDF for the full reference.]

[13] ÈþÿóçÝÏÂÝ·ªÏž•ž•ž·ž•ž•ž‰zhhhhV"hÔ!âh€à5�6�CJOJQJaJ"hÔ!âhf3F5�6�CJOJQJaJh^~ h˜gCJOJQJaJh^~ CJOJQJaJh€à6�OJQJh€àh€à6�OJQJh€àh^~ OJPJQJh€àH*OJPJQJh€àh€àOJPJQJh€àh€àH*OJPJQJh€àOJPJQJh€àCJ(OJPJQJh€àh€àCJ(OJQJ[\~= Æ Ç È ÿt„…nòÝȳ³¡¡™™ˆwi [Some characters in this reference could not be displayed correctly — please refer to the published PDF for the full reference.]

[14] [Some characters in this reference could not be displayed correctly — please refer to the published PDF for the full reference.]

@article{1708262,
      author = {G. Selvakumar, Dr. G. Rajendran},
      title = {Machine Learning Based Drug Repurposing Strategies for Predicting Drug-Target Interactions},
      journal = {Iconic Research And Engineering Journals},
      year = {2025},
      volume = {8},
      number = {11},
      pages = {144-153},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1708262.pdf},
      abstract = {The process of discovering and developing a drug is not at all a routine but rather a time consuming and complex process. A large number of potential components of a drug may have the possibility to get rejected on the ground of toxicity. Drug repositioning is a very important aspect of drug discovery; it refers to the identification of new targets for already existing or abandoned drugs. Computational prediction of the binding affinity between the chemical compounds and the protein targets has a major role in reducing the need for wet-lab analysis on large scales, hence improving the chances of identification of lead compounds. Even more recently, ML and deep learning methods have been used for predicting drug-target interactions, which has effectively reduced much time and cost that went with the effort of drug discovery. Proteins that drugs target fall into four big categories: enzymes, ion channels, G-protein-coupled receptors, and nuclear receptors. Principles of drug repurposing broadly fall into two categories: drug-based and disease-based. This analysis will give whether a single drug can treat multiple diseases in resemblance for drug-based repurposing. On the other hand, in the disease-based repurposing, new applications are sought from existing drugs in known targets. Several in-silico methodologies have been widely explored, especially the machine learning approaches, for predicting potential drug-target interactions. This work, therefore, aims at reviewing some of the methodologies of drug repurposing and their applications in the process of drug discovery and development using machine learning models. With the vast availability of biological data and computational resources for researchers, the aim would be the exploitation of these tools to further facilitate the process of drug discovery.},
      keywords = {Machine Learning, Deep Learning, Drug Discovery, Drug Repurposing, Drug-Target Interaction Prediction},
      month = {May},
  }